Evidence map›Paper›PMID 31280221›Full record

ArticleIn vivo (Athens, Greece)

Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma.

Khaled Elsayad, Denise Stockmann, Mohammed Channaoui, Sergiu Scobioala, Aneta Grajda, Hendrik Berssenbrügge, Sebastian Huss, Christos Moustakis, Uwe Haverkamp, Johannes Kleinheinz and 3 more

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Khaled ElsayadDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany Khaled.elsayad@uni-muenster.de.
Denise StockmannDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
Mohammed ChannaouiDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
Sergiu ScobioalaDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
Aneta GrajdaDepartment of Radiation Oncology, Paracelsus Clinic, Osnabruck, Germany.
Hendrik BerssenbrüggeDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Muenster, Muenster, Germany.
Sebastian HussGerhard Domagk Institute of Pathology, University Hospital Muenster, Muenster, Germany.
Christos MoustakisDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
Uwe HaverkampDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
Johannes KleinheinzDepartment of Cranio-Maxillofacial Surgery, University Hospital Muenster, Muenster, Germany.
Georg LenzDepartment of Medicine A, University Hospital Muenster, Muenster, Germany.
Eva WardelmannGerhard Domagk Institute of Pathology, University Hospital Muenster, Muenster, Germany.
Hans Theodor EichDepartment of Radiation Oncology, University Hospital Muenster, Muenster, Germany.
University Hospital Münster · DEParacelsus-Kliniken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImage-guided intensity-modulated radiotherapy (IG-IMRT) is increasingly being used to treat patients with soft-tissue sarcoma (STS) of the head and neck. Although there is no comparison between IMRT and conventional radiation therapy (CRT) concerning their efficacy. In this analysis, we compared CRT and IMRT outcomes for head and neck STS. PATIENTS AND

methodsSixty-seven patients who underwent radiotherapy between 1994 and 2017 were identified.

resultsThe median follow-up was 31 months. Of the 67 patients, 34% were treated with CRT technique and 66% with IG-IMRT. The locoregional relapse rate following IMRT was 21% versus 70% with CRT (p<0.001) and the 5-year locoregional control was 69% versus 28%, respectively (p=0.01). IG-IMRT was associated with non-significant, less acute, and chronic adverse events. In the multivariate analysis, a significant influence of radiation technique on locoregional control was confirmed (p=0.04).

conclusionIG-IMRT seems to be associated both with higher locoregional control as well as lower acute and chronic toxicities.

Indexed as

Radiotherapy, Image-GuidedRadiotherapy, Intensity-ModulatedAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedMultimodal ImagingNeoplasm GradingNeoplasm StagingHead and neck sarcomaimage-guided radiotherapyimmunotherapyIMRTlocal controlprognosis

Identifiers

PMID31280221
PMCPMC6689378
OpenAlexW2955148127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.